| Document |
Document Title |
|
WO/2014/129268A1 |
Provided are: a liquid crystal compound satisfying at least one property such as high stability to light, high clearing point, low minimum temperature of the liquid crystal phase, low viscosity, suitable optical anisotropy, large dielect...
|
|
WO/2014/125970A1 |
The present invention provides a novel fused polycyclic compound suitably used for a blue light emitting element and an organic light emitting element including the fused polycyclic compound. A fused polycyclic compound is represented by...
|
|
WO/2014/125075A1 |
The present invention relates to a antibiotically active compounds characterized by general formula (I), wherein X1, BB, BC, BD, BE and X2 are building blocks with D1, D2, D3, D4 or D5 being linkers which comprise carbon, sulphur, nitrog...
|
|
WO/2014/122267A1 |
The present invention belongs to the field of EP4 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP4 receptor. The invention also refers to the process for ...
|
|
WO/2014/112646A1 |
The present invention addresses the problem of providing a compound having a selective inhibitory activity on LAT-1 that can be expressed in a tumor cell at a high level. The present invention provides: a compound represented by formula ...
|
|
WO/2014/111980A1 |
The present invention provides: a Janus-type triptycene derivative which is represented by general formula [I] and is useful as a material for a self-assembled monomolecular film; a Janus-type triptycene derivative which is represented b...
|
|
WO/2014/106766A1 |
The invention relates to a process for the synthesis of a monounsaturated nitrile-ester (acid) by cross metathesis starting from an unsaturated compound comprising at least one trivalent nitrile, acid or ester functional group, character...
|
|
WO/2014/103685A1 |
Provided are: a compound which has a spicy aroma useful as an aroma chemical, particularly a cumin-like aroma, is stable in an aqueous medium, can emphasize various aromas including a spicy aroma, a green aroma, a floral aroma, a woody a...
|
|
WO/2014/086723A1 |
The invention relates to the use of substituted 1 -(aryl ethynyl)-, 1 - (heteroaryl ethynyl)-, 1 -(heterocyclyl ethynyl)- and 1 -(cyloalkenyl ethynyl)- bicycloalkanols or salts thereof (I). The groups in general formula (I) correspond to...
|
|
WO/2014/089343A1 |
Pentenenitrile oligomers formed in a process for isomerizing cis-2-pentenenitrile to 3-pentenenitrile are minimized in the presence of an aluminium oxide catalyst. The process comprises providing an aluminium oxide catalyst having an alk...
|
|
WO/2014/087298A1 |
The present invention relates to a compound of Formula 1, 2 or 3: wherein A is N or –CR0 --, where R0 is hydrogen, C1 -C6 linear or branched chain alkyl, etc., Z is –CRe --, or, –N--, where Re is hydrogen, C1 -C6 linear or branched...
|
|
WO/2014/082022A1 |
A process for preparation of catalysts for the production of acrylonitrile, acetonitrile and hydrogen cyanide comprising contacting at an elevated temperature, propylene, ammonia and oxygen in the vapor phase in the presence of a catalys...
|
|
WO/2014/081168A1 |
The present specification provides a novel fluoranthene compound and an organic electronic device having an organic compound layer containing said compound, wherein the novel fluoranthene compound can remarkably improve the lifespan, eff...
|
|
WO/2014/075754A1 |
Compounds of the formula (I) in which R1, R4, R, X1, X2, X3, X4, q and W have the meanings indicated in Claim 1, are inhibitors of fatty acid synthase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardio...
|
|
WO/2014/072419A1 |
The present invention relates to the field of HIV-1 infections, and in particular provides novel compounds containing fluorine on the Central ring. The compounds according to this invention are very suitable for the prevention and/or tre...
|
|
WO/2014/073672A1 |
This method for producing an aldehyde compound comprises a step for reacting a compound represented by general formula (a1) or general formula (a2) with hydrogen and carbon monoxide in the presence of a phosphorus compound and a metal co...
|
|
WO/2014/073664A1 |
This method for producing an aldehyde compound comprises a step for reacting a compound represented by general formula (a1) with hydrogen and carbon monoxide in the presence of a phosphorus compound and a metal compound that contains 0.0...
|
|
WO/2014/075093A1 |
The present invention relates to compounds that inhibit VIPR2 in the CNS, pharmaceutical compositions comprising said compounds, and methods of using such compounds and compositions in the treatment of a CNS disorder such as a behavioral...
|
|
WO/2014/073663A1 |
This method for purifying an aldehyde compound comprises: a step for neutralizing a reaction solution, which contains an aldehyde compound that is obtained by reacting a compound represented by general formula (a1) or (a2) with hydrogen ...
|
|
WO/2014/073003A1 |
The present invention relates to the single-step process for the synthesis of aryl olefin compounds of Formula (1) by reacting aryl aldehydes with alkyl aldehydes in presence of malononitrile and acid or base or salt, optionally in prese...
|
|
WO/2014/000629A9 |
The invention relates to hexahydropentaleno derivatives, the preparation method and use in medicine thereof, and in particular to hexahydropentaleno derivatives or stereo-isomers or pharmaceutically acceptable salts thereof as shown in g...
|
|
WO/2014/069555A1 |
Provided is a compound that exhibits an excellent melanogenesis-inhibiting effect (skin-lightening effect), exhibits an excellent antimicrobial effect, excels in terms of temporal stability and the like, and is suitable for use as an ing...
|
|
WO/2014/066772A1 |
This disclosure relates to processes and reagents for making diaryliodonium salts, which are useful for the preparation of fluorinated, iodinated, astatinated and radiofluorinated aromatic compounds.
|
|
WO/2014/056421A1 |
Provided are a 1-cyan-1-(7-methoxyl-1-naphtyl) methanol ester compound, and preparation method and use thereof in the preparation of agomelatine intermediate 2-(7-methoxyl-1-naphtyl) ethylamine. Also provided is an agomelatine preparatio...
|
|
WO/2014/057874A1 |
The purpose of the present invention is to provide an organic thin-film luminescent element which exhibits improved luminous efficiency, drive voltage and durability life. This fluoranthene derivative is characterized by having a specifi...
|
|
WO/2014/056939A1 |
The present invention relates to novel compounds, particularly for use as additives in a lipidic cubic phase material, and to novel lipidic cubic phase materials. These materials are biocompatible, stable and transparent and can encapsul...
|
|
WO/2014/057228A1 |
A method for synthesising the compound of formula (I): Application to the synthesis of ivabradine, the addition salts thereof with a pharmaceutically acceptable acid, and the hydrates thereof.
|
|
WO/2014/054408A1 |
The purpose of the present invention is to provide a method for safely and quickly stopping ammoxidation without reducing catalytic activity or the acrylonitrile yield in the case of stopping ammoxidation of propane. Provided is a method...
|
|
WO/2014/053694A1 |
Compounds of formula I, wherein A, B, X, Z and R1-R6, are as defined in the claims, exhibit TRPA 1 activity and are thus useful as TRPA1 modulators.
|
|
WO/2014/051090A1 |
The purpose of the present invention is to provide: an oxide catalyst which is suppressed in reduction degradation of the catalyst even in a long time industrial operation, while being small in decrease of the yield of an unsaturated ald...
|
|
WO/2014/050272A1 |
The present invention mainly addresses the problem of providing a method for producing a complex composed of an organic nitrogen compound and a copper (I) salt of a fluorooxo acid with high yield while reducing the corrosion of a reactio...
|
|
WO/2014/050615A1 |
This composite oxide catalyst is used for a vapor-phase catalytic oxidation reaction or vapor-phase catalytic ammoxidation reaction of propane or isobutane, and contains a composite oxide that is represented by a composition formula Mo1V...
|
|
WO/2014/048547A1 |
The present invention relates to alpha hydroxy amides including compounds of formula (I) and related compounds and their use in the prophylaxis and treatment of inflammatory disorders and diseases, wherein T1, T2, W and Rw has the meanin...
|
|
WO/2014/051521A1 |
The present invention relates to methods and compositions for detecting an interaction between a protein and a ligand, comprising: (i) binding at least one fluorescent molecular rotor to said ligand or protein; and (ii) detecting a chang...
|
|
WO/2014/052889A1 |
Disclosed are salicylate-based compounds, compositions including the compounds, processes for preparing the compounds, and methods of using the compounds. The compounds may be used for the treatment or prevention of various diseases and ...
|
|
WO/2014/039917A1 |
Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases o...
|
|
WO/2014/035203A1 |
The present specification relates to a styryl-based compound, to a coloring material comprising the styryl-based compound, to a photosensitive resin composition comprising the coloring material, to a photoresist material prepared from th...
|
|
WO/2014/034500A1 |
This method for purifying acetonitrile comprises: a step for obtaining a reaction liquid by supplying an alkali and crude acetonitrile, which has been obtained by an ammoxidation reaction, into a reaction tank; a step for obtaining a liq...
|
|
WO/2014/034891A1 |
This organic electroluminescent element comprises a negative electrode, a positive electrode, and one or more organic layers that are arranged between the negative electrode and the positive electrode and include at least a light emittin...
|
|
WO/2014/034864A1 |
This organic electroluminescence element is characterized by being provided with a positive electrode, a negative electrode disposed opposite of the positive electrode, and an organic layer disposed between the positive electrode and the...
|
|
WO/2014/031226A1 |
Methods and systems are provided for converting methane in a feed stream to acetylene. The hydrocarbon stream is introduced into a supersonic reactor and pyrolyzed to convert at least a portion of the methane to acetylene. The reactor ef...
|
|
WO/2014/025370A1 |
A method of quenching excited state energy from a photodegradable pigment that has been excited by absorption of light having a wavelength in the wavelength range of 290 - 800 nm, comprising reacting a pigment with a conjugated fused tri...
|
|
WO/2014/024687A1 |
A novel organic compound suitable for blue-light-emitting devices and an organic light-emitting device including the compound are provided. An organic compound represented by Formula [1] according to Claim 1 is provided. In Formula [1], ...
|
|
WO/2014/014307A1 |
According to one embodiment of the present application, a novel compound and an organic electronic device using the same are provided, and the efficiency, driving voltage, and lifetime of the organic electronic device are remarkable.
|
|
WO/2014/012467A1 |
Provided is a diarylaniline or diarylpyridinamine compound and the preparation method and use thereof for preparing a drug. The compound has strong inhibition activity against wild-type and various resistant HIV viral strains (nM level) ...
|
|
WO/2014/012466A1 |
Provided are compounds of diarylanilines and diarylpyridinamines, a preparation method therefor, and uses thereof. The compounds have strong inhibitory activity (nM level) for a wild-type and multiple drug-resistant HIV strains, have goo...
|
|
WO/2014/012935A1 |
The present application relates to novel substituted aminoindane- and aminotetralincarboxylic acids, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases and to the use thereof for producti...
|
|
WO/2014/013261A1 |
The present invention provides a use of Iithium amide in liquid ammonia as a base to produce an enolate from at least one ester starting material in a crossed Claisen condensation reaction, wherein at least one ester starting material is...
|
|
WO/2014/013151A1 |
The present invention relates to a method for manufacturing diaminomaleonitrile, characterised in that said method includes at least one step during which a cyanohydrin ketone with formula RR'COHCN, R and R', which are the same or differ...
|
|
WO/2014/005134A2 |
The present teachings provide a compound of Formula (I-B): wherein R1-R10 are as described herein; a pharmaceutically acceptable salt of the compound, a geometric isomer of the compound, or a pharmaceutically acceptable salt of the geome...
|
